| http://www.w3.org/ns/prov#value | - genic site wherein said antibody is an antibody obtained from a culture of a hybrid continuous cell line having the identifying characteristics of A.T.C.C. HB8530 or a binding fragment of said antibody, and (b) observing the presence of binding of said antibody to said antigenic site, the binding of said antibody being related to the presence of neoplastic cells in said specimen. 4.
|
